These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32840824)

  • 1. Antibodies as Currency: COVID-19's Golden Passport.
    Bramstedt KA
    J Bioeth Inq; 2020 Dec; 17(4):687-689. PubMed ID: 32840824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity passports to travel during the COVID-19 pandemic: controversies and public health risks.
    Liew CH; Flaherty GT
    J Public Health (Oxf); 2021 Apr; 43(1):e135-e136. PubMed ID: 32756915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passport to freedom? Immunity passports for COVID-19.
    Brown RCH; Savulescu J; Williams B; Wilkinson D
    J Med Ethics; 2020 Oct; 46(10):652-659. PubMed ID: 32817362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Immunity Passport to Ease Travel Restrictions?
    Chen LH; Freedman DO; Visser LG
    J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32463093
    [No Abstract]   [Full Text] [Related]  

  • 5. Papers Please - Predictive Factors of National and International Attitudes Toward Immunity and Vaccination Passports: Online Representative Surveys.
    Garrett PM; White JP; Dennis S; Lewandowsky S; Yang CT; Okan Y; Perfors A; Little DR; Kozyreva A; Lorenz-Spreen P; Kusumi T; Kashima Y
    JMIR Public Health Surveill; 2022 Jul; 8(7):e32969. PubMed ID: 35377317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical Implementation of Immunity Passports During the COVID-19 Pandemic.
    Voo TC; Clapham H; Tam CC
    J Infect Dis; 2020 Aug; 222(5):715-718. PubMed ID: 32582943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [UNESCO on COVID-19: Ethical Guidelines for a Global Response].
    Vivanco L
    Cuad Bioet; 2020; 31(102):269-273. PubMed ID: 32910675
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns.
    Sharun K; Tiwari R; Dhama K; Rabaan AA; Alhumaid S
    Hum Vaccin Immunother; 2021 Nov; 17(11):4108-4111. PubMed ID: 34292128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B careful: Humoral responses and COVID-19 severity.
    Fanous H; Guerrero-Pena A; Pillai A
    Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33277373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Immunity Passports' for SARS-CoV-2: an online experimental study of the impact of antibody test terminology on perceived risk and behaviour.
    Waller J; Rubin GJ; Potts HWW; Mottershaw AL; Marteau TM
    BMJ Open; 2020 Aug; 10(8):e040448. PubMed ID: 32868370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: Significance of antibodies.
    Assadiasl S; Fatahi Y; Zavvar M; Nicknam MH
    Hum Antibodies; 2020; 28(4):287-297. PubMed ID: 32986664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing CD8
    Gujar S; Pol JG; Kim Y; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.
    Liu T; Hsiung J; Zhao S; Kost J; Sreedhar D; Hanson CV; Olson K; Keare D; Chang ST; Bliden KP; Gurbel PA; Tantry US; Roche J; Press C; Boggs J; Rodriguez-Soto JP; Montoya JG; Tang M; Dai H
    Nat Biomed Eng; 2020 Dec; 4(12):1188-1196. PubMed ID: 33122853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.
    Jiang JC; Zhang Y
    Biochem Soc Trans; 2020 Dec; 48(6):2851-2863. PubMed ID: 33170924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19's impact on travel medicine surpasses that of all other emerging viral diseases.
    Leong WY
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 33247591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to SARS-CoV-2 in people living with HIV.
    Yamamoto S; Saito M; Nagai E; Toriuchi K; Nagai H; Yotsuyanagi H; Nakagama Y; Kido Y; Adachi E
    J Microbiol Immunol Infect; 2021 Feb; 54(1):144-146. PubMed ID: 33046418
    [No Abstract]   [Full Text] [Related]  

  • 20. Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?
    Takahashi S; Greenhouse B; Rodríguez-Barraquer I
    J Infect Dis; 2020 Nov; 222(11):1772-1775. PubMed ID: 32856712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.